immune-cells-cancer-treatment

Head and Neck Cancer Clinical Trial

If you or a family member 18 years of age or older has been diagnosed with cancer of the throat or mouth, you may qualify for a clinical trial and will receive study treatment and compensation. Please click on the link below for more information:

The mold spores grow in human lungs illustration

Limited-stage small cell lung cancer (LS-SCLC)

If you are 18 years of age or older and have been diagnosed and treated for LS-SCLC with concurrent chemotherapy and radiation therapy, you may qualify for a clinical study.

  • To qualify, you must have completed chemoradiotherapy without progression.
  • Participants may receive compensation.
  • Please contact us for more information.

  • 2147797832 (1)

    Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    We are enrolling participants 18 and older in a clinical study for Lymphoma. To qualify, you must have been diagnosed with Diffuse Large B-Cell Lymphoma. In addition, you must:

  • Have relapsed or refractory disease and
  • Have previously been treated with at least 1 prior systemic antineoplastic therapies including at least 1 anti-CD20 monoclonal antibody- containing therapy

    You may also qualify for the study if you have:
  • Failed prior autologous hematopoietic stem cell transplantation (HSCT), or
  • Are ineligible for autologous HSCT due to age, Eastern Cooperative Oncology Group (ECOG) performance status, comorbidities and/or insufficient response to prior treatment.

    Participants may receive compensation and study treatment. Please contact us for more information.

  • Contact Us Today: 
    3465 Nazareth Road,

    Suite 102
    Easton, PA 18045

    Phone: 717-819-9982

    Text: 717-819-9982

    Email: info@spoknwrdclinicaltrials.com